Form 4: Amgen EVP, Operations, Esteban Santos, Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Esteban Santos, EVP of Operations at Amgen, exercised stock options and sold shares on February 19, 2025.
Summary
- On February 19, 2025, Esteban Santos, the EVP of Operations at Amgen, exercised stock options to acquire 8,711 shares of Amgen common stock at a price of $156.35 per share.
- Simultaneously, Santos sold 8,711 shares of Amgen common stock at an average price of $292.837, with prices ranging from $292.7523 to $293.00 per share.
- Following these transactions, Santos directly owns 71,546 shares of Amgen common stock and indirectly owns 868.8725 shares through the company's 401(k) plan.
- The exercised stock options were set to expire on May 3, 2026, and were granted on May 3, 2018.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a routine transaction. There is no indication of positive or negative sentiment towards the company's performance or future outlook.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies like Amgen. These transactions are closely watched by investors for signals about management's confidence in the company's future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The exercise and sale of shares by Esteban Santos is a typical event for executives holding stock options.
- Similar transactions are regularly reported by executives at comparable companies in the biotechnology and pharmaceutical industries, such as Johnson & Johnson, Pfizer, and Roche.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- Shareholders may view insider transactions as a signal of management's confidence, but this particular transaction appears routine.
Key Dates
| Date | Description |
|---|---|
| 05/03/2018 | Date the Non-Qualified Stock Options (NQSO) were granted. |
| 02/19/2025 | Date of stock option exercise and sale of shares. |
| 02/21/2025 | Date of Form 4 filing. |
| 05/03/2026 | Expiration date of the stock options. |
Keywords
Amgen, Esteban Santos, stock options, Form 4, insider trading, executive compensation, AMGN, EVP Operations, stock sale, 401k
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.